Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 0 | 3,264 | 0 | 2,111 | 0 |
| Operating Income | N/A | -3,264 | N/A | -2,111 | N/A |
| Interest Expense | 0 | 23 | 0 | 13 | 0 |
| Other Income | 0 | 572 | 0 | 0 | 0 |
| Pre-tax Income | 0 | -2,715 | 0 | -2,124 | 0 |
| Net Income Continuous | N/A | -2,715 | N/A | -2,124 | N/A |
| Net Income | $N/A | $-2,715 | $N/A | $-2,124 | $N/A |
| EPS Basic Total Ops | N/A | -0.24 | N/A | -0.38 | N/A |
| EPS Basic Continuous Ops | N/A | -0.24 | N/A | -0.38 | N/A |
| EPS Diluted Total Ops | N/A | -0.24 | N/A | -0.38 | N/A |
| EPS Diluted Continuous Ops | N/A | -0.24 | N/A | -0.38 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.31 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $N/A | $-3,264 | $N/A | $-2,111 | $N/A |